Literature DB >> 32936340

Screening for Mental Health and Substance Use Disorders in Obstetric Settings.

Nancy Byatt1, Grace A Masters2, Aaron L Bergman2, Tiffany A Moore Simas2.   

Abstract

PURPOSE OF REVIEW: The objective of this review is to describe the extent to which (1) obstetric settings are currently screening for mental health and substance use disorders and social determinants of health (SDoH), and (2) screening is followed by systematic approaches for ensuring an adequate response to positive screens. Additionally, clinical and policy implications of current screening practices and recommendations are discussed. RECENT
FINDINGS: Screening for perinatal depression in obstetric settings has increased. Despite their prevalence and negative impact, screening for other mental health and substance use disorders and SDoH is much less common and professional society recommendations are either nonexistent, less consistent, or less prescriptive. To truly address maternal mental health, we need to move beyond focusing solely on depression and address other mental health and substance use disorders and the contextual social determinants in which they occur.

Entities:  

Keywords:  Anxiety; Depression; Mood disorder; Perinatal; Pregnancy; Screening

Year:  2020        PMID: 32936340     DOI: 10.1007/s11920-020-01182-z

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  2 in total

1.  A Non-Randomized Trial of In-Person Versus Text/Telephone Screening, Brief Intervention and Referral to Treatment for Pregnant and Postpartum Women.

Authors:  Constance Guille; Lizmarie Maldonado; Annie N Simpson; Roger Newman; Courtney King; Bernadette Cortese; Erin Quigley; Nicole Dietrich; Anna Kerr; Rubin Aujla; Kathryn King; Dee Ford; Kathleen T Brady
Journal:  Psychiatr Res Clin Pract       Date:  2021-11-18

2.  Development of the Practice Readiness to Evaluate and address Perinatal Depression (PREPD) assessment.

Authors:  Grace A Masters; Linda Brenckle; Padma Sankaran; Tiffany A Moore Simas; Sharina D Person; Jeroan Allison; Douglas Ziedonis; Jean Ko; Cheryl Robbins; Nancy Byatt
Journal:  Psychiatry Res       Date:  2021-05-29       Impact factor: 11.225

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.